Radiology, Vol 200, 483-488, Copyright © 1996 by Radiological Society of North America

ARTICLES

Benign and malignant gynecologic disease: clinical importance of fluid and peritoneal enhancement in the pelvis at MR imaging

EK Outwater, ES Siegelman, KM Wilson and DG Mitchell
Department of Radiology, Thomas Jefferson University Hospital, Philadelphia, PA 19107-5244, USA.

PURPOSE: To correlate magnetic resonance (MR) imaging findings of pelvic fluid, peritoneal enhancement, and peritoneal nodules with the presence of benign or malignant pelvic disease. MATERIALS AND METHODS: Pelvic MR imaging findings in 87 women (mean age, 46 years) who subsequently underwent surgery were retrospectively reviewed. Phased- array multicoil, axial spin-echo T1-weighted MR images and axial fast spin-echo T2-weighted images were obtained. The largest pelvic fluid pocket was measured on the T2-weighted images in three orthogonal dimensions. Peritoneal enhancement and nodules were evaluated on gadolinium-enhanced MR images in 54 women. RESULTS: Pelvic fluid was shown in 21 of 25 patients with malignant neoplasms and 48 of 62 patients with benign disorders. Larger fluid pockets were associated with malignancy rather than with benign disorders, but there was substantial overlap. Use of peritoneal enhancement to diagnose peritoneal spread of tumor had a sensitivity, specificity, accuracy, and positive predictive value of 92% (11 of 12), 86% (36 of 42), 87% (47 of 54), and 65% (11 of 17), respectively. Use of peritoneal nodules for peritoneal spread had a higher specificity (90% [38 of 42]) and positive predictive value (69% [nine of 13]), although the sensitivity was lower (75% [nine of 12]). CONCLUSION: Large peritoneal fluid pockets are moderately predictive of malignancy or peritoneal spread of tumor. Peritoneal enhancement and enhancing peritoneal nodules are more sensitive and more specific.

This article has been cited by other articles:

				R. N. Low, B. Duggan, R. M. Barone, F. Saleh, and S. Y. T. Song Treated Ovarian Cancer: MR Imaging, Laparotomy Reassessment, and Serum CA-125 Values Compared with Clinical Outcome at 1 Year Radiology, June 1, 2005; 235(3): 918 - 926. [Abstract] [Full Text] [PDF]

				P. J. Woodward, K. Hosseinzadeh, and J. S. Saenger From the Archives of the AFIP: Radiologic Staging of Ovarian Carcinoma with Pathologic Correlation RadioGraphics, January 1, 2004; 24(1): 225 - 246. [Abstract] [Full Text] [PDF]

				Y.-Y. Jeong, E. K. Outwater, and H. K. Kang Imaging Evaluation of Ovarian Masses RadioGraphics, September 1, 2000; 20(5): 1445 - 1470. [Abstract] [Full Text] [PDF]

				A. S. Fulcher, S. G. O'Sullivan, E. M. Segreti, and B. D. Kavanagh Recurrent Cervical Carcinoma: Typical and Atypical Manifestations RadioGraphics, October 1, 1999; 19(90001): 103 - 116. [Abstract] [Full Text]

				A. B. Kurtz, J. V. Tsimikas, C. M. C. Tempany, U. M. Hamper, P. H. Arger, R. L. Bree, R. J. Wechsler, I. R. Francis, J. E. Kuhlman, E. S. Siegelman, et al. Diagnosis and Staging of Ovarian Cancer: Comparative Values of Doppler and Conventional US, CT, and MR Imaging Correlated with Surgery and Histopathologic Analysis—Report of the Radiology Diagnostic Oncology Group Radiology, July 1, 1999; 212(1): 19 - 27. [Abstract] [Full Text]

				R. N. Low, F. Saleh, S. Y. Thomas Song, T. A. Shiftan, R. M. Barone, C. G. Lacey, and P. M. Goldfarb Treated Ovarian Cancer: Comparison of MR Imaging with Serum CA-125 Level and Physical Examination—A Longitudinal Study Radiology, May 1, 1999; 211(2): 519 - 528. [Abstract] [Full Text]